116 related articles for article (PubMed ID: 38622983)
21. Panax notoginseng saponin alleviates pulmonary fibrosis in rats by modulating the renin-angiotensin system.
Li H; Wang YG; Chen TF; Gao YH; Song L; Yang YF; Gao Y; Huo W; Zhang GP
J Ethnopharmacol; 2024 Jan; 318(Pt B):116979. PubMed ID: 37532070
[TBL] [Abstract][Full Text] [Related]
22. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y
J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337
[TBL] [Abstract][Full Text] [Related]
23. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action.
Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019
[TBL] [Abstract][Full Text] [Related]
24. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
25. Panax notoginseng saponins alleviate damage to the intestinal barrier and regulate levels of intestinal microbes in a rat model of chronic kidney disease.
Xie J; Ma X; Zheng Y; Mao N; Ren S; Fan J
Ren Fail; 2022 Dec; 44(1):1948-1960. PubMed ID: 36354128
[TBL] [Abstract][Full Text] [Related]
26.
Zhao Y; Zheng J; Yu Y; Wang L
Biomed Res Int; 2018; 2018():9239354. PubMed ID: 30151392
[No Abstract] [Full Text] [Related]
27. Feikang granules ameliorate pulmonary inflammation in the rat model of chronic obstructive pulmonary disease via TLR2/4-mediated NF-κB pathway.
Yang L; Wen M; Liu X; Wang K; Wang Y
BMC Complement Med Ther; 2020 Jun; 20(1):170. PubMed ID: 32493287
[TBL] [Abstract][Full Text] [Related]
28. Effects of atorvastatin in suppressing pulmonary vascular remodeling in rats with chronic obstructive pulmonary disease.
He Y; Wang S; Li Y; Deng J; Huang L
Clinics (Sao Paulo); 2023; 78():100252. PubMed ID: 37459672
[TBL] [Abstract][Full Text] [Related]
29. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
[TBL] [Abstract][Full Text] [Related]
30. [Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
Zhang S; Tian YN; Song ZY; Wang XT; Wang XY; Xu JP; Yuan LB; Wang WT
Sheng Li Xue Bao; 2023 Aug; 75(4):503-511. PubMed ID: 37583037
[TBL] [Abstract][Full Text] [Related]
31. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats.
Du YG; Wang LP; Qian JW; Zhang KN; Chai KF
Chin J Integr Med; 2016 Dec; 22(12):910-917. PubMed ID: 26712211
[TBL] [Abstract][Full Text] [Related]
32. Activation of hypoxia-inducible factor-1alpha via nuclear factor-kappa B in rats with chronic obstructive pulmonary disease.
Jiang H; Zhu Y; Xu H; Sun Y; Li Q
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):483-8. PubMed ID: 20705587
[TBL] [Abstract][Full Text] [Related]
33. Electroacupuncture attenuates pulmonary vascular remodeling in a rat model of chronic obstructive pulmonary disease via the VEGF/PI3K/Akt pathway.
Zhang L; Tian Y; Zhao P; Jin F; Miao Y; Liu Y; Li J
Acupunct Med; 2022 Aug; 40(4):389-400. PubMed ID: 35216533
[TBL] [Abstract][Full Text] [Related]
34. [Effect of aminophylline and simvastatin on airway inflammation and mucus hypersecretion in rats with chronic obstructive pulmonary disease].
Wang S; Xiong L; Deng X; Zhou Q; Li C; Ren W; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):37-43. PubMed ID: 26819423
[TBL] [Abstract][Full Text] [Related]
35. Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury.
Zhu B; Zhang W; Lu Y; Hu S; Gao R; Sun Z; Chen X; Ma J; Guo S; Du S; Li P
Biomed Pharmacother; 2018 Sep; 105():159-166. PubMed ID: 29857294
[TBL] [Abstract][Full Text] [Related]
36. Panax notoginseng saponins inhibits oxidative stress- induced human nucleus pulposus cell apoptosis and delays disc degeneration in vivo and in vitro.
Guo D; Yu M; Guo H; Zeng M; Shao Y; Deng W; Qin Q; Li Y; Zhang S
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117166. PubMed ID: 37716491
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of altered TNF-alpha expression by macrophage and the modulatory effect of Panax notoginseng saponins in scald mice.
Wang Y; Peng D; Huang W; Zhou X; Liu J; Fang Y
Burns; 2006 Nov; 32(7):846-52. PubMed ID: 16814471
[TBL] [Abstract][Full Text] [Related]
38. Panax notoginseng saponins normalises tumour blood vessels by inhibiting EphA2 gene expression to modulate the tumour microenvironment of breast cancer.
Xia L; Liu X; Mao W; Guo Y; Huang J; Hu Y; Jin L; Liu X; Fu H; Du Y; Shou Q
Phytomedicine; 2023 Jun; 114():154787. PubMed ID: 37060724
[TBL] [Abstract][Full Text] [Related]
39. Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy.
Wang Y; Ma P; Wang Z; Sun M; Hou B; Xu T; Li W; Yang X; Du G; Ji T; Qiang G
J Ethnopharmacol; 2023 Jan; 300():115680. PubMed ID: 36058479
[TBL] [Abstract][Full Text] [Related]
40. Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis.
Yang Q; Wang P; Cui J; Wang W; Chen Y; Zhang T
J Ethnopharmacol; 2016 Dec; 193():255-265. PubMed ID: 27566197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
